These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27262199)

  • 1. Isoferulic Acid Action against Glycation-Induced Changes in Structural and Functional Attributes of Human High-Density Lipoprotein.
    Jairajpuri DS; Jairajpuri ZS
    Biochemistry (Mosc); 2016 Mar; 81(3):289-95. PubMed ID: 27262199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycation of human high density lipoprotein by methylglyoxal: effect on HDL-paraoxonase activity.
    Bacchetti T; Masciangelo S; Armeni T; Bicchiega V; Ferretti G
    Metabolism; 2014 Mar; 63(3):307-11. PubMed ID: 24360750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoferulic acid prevents methylglyoxal-induced protein glycation and DNA damage by free radical scavenging activity.
    Meeprom A; Sompong W; Suantawee T; Thilavech T; Chan CB; Adisakwattana S
    BMC Complement Altern Med; 2015 Oct; 15():346. PubMed ID: 26438049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity.
    Ferretti G; Bacchetti T; Marchionni C; Caldarelli L; Curatola G
    Acta Diabetol; 2001 Dec; 38(4):163-9. PubMed ID: 11855794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of homocysteinylation on high density lipoprotein physico-chemical properties.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Chem Phys Lipids; 2010 Feb; 163(2):228-35. PubMed ID: 19962972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro.
    Meeprom A; Sompong W; Chan CB; Adisakwattana S
    Molecules; 2013 May; 18(6):6439-54. PubMed ID: 23722732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
    Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of inhibitory effect of isoferulic acid on mushroom tyrosinase.
    Gong S; Yin M; Yun Z
    J Cosmet Sci; 2013; 64(4):235-41. PubMed ID: 23931087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of advanced glycation end products by isoferulic acid and its free radical scavenging capacity: An in vitro and molecular docking study.
    Arfin S; Siddiqui GA; Naeem A; Moin S
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1479-1487. PubMed ID: 29969636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H; Tan KC; Shiu SW; Wong Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin.
    Mera K; Takeo K; Izumi M; Maruyama T; Nagai R; Otagiri M
    J Pharm Sci; 2010 Mar; 99(3):1614-25. PubMed ID: 19760671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
    Zago V; Sanguinetti S; Brites F; Berg G; Verona J; Basilio F; Wikinski R; Schreier L
    Atherosclerosis; 2004 Nov; 177(1):203-10. PubMed ID: 15488885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.